Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | neuropeptide Y receptor Y1 | Starlite/ChEMBL | References |
Homo sapiens | neuropeptide Y receptor Y2 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Schistosoma japonicum | ko:K04209 neuropeptide Y receptor, invertebrate, putative | Get druggable targets OG5_127863 | All targets in OG5_127863 |
Echinococcus multilocularis | neuropeptide receptor | Get druggable targets OG5_127863 | All targets in OG5_127863 |
Schistosoma mansoni | neuropeptide receptor | Get druggable targets OG5_127863 | All targets in OG5_127863 |
Echinococcus granulosus | neuropeptide receptor | Get druggable targets OG5_127863 | All targets in OG5_127863 |
Echinococcus multilocularis | G protein coupled receptor 139 | Get druggable targets OG5_127863 | All targets in OG5_127863 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus granulosus | pyroglutamylated rfamide peptide receptor | neuropeptide Y receptor Y2 | 381 aa | 388 aa | 20.4 % |
Brugia malayi | follicle stimulating hormone receptor | neuropeptide Y receptor Y1 | 384 aa | 345 aa | 22.0 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0271 | 1 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.0091 | 0.0271 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0271 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0271 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0271 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0477 | 0.334 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0271 | 1 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.0091 | 0.0271 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0271 | 1 |
Echinococcus multilocularis | G protein coupled receptor 139 | 0.0193 | 0.1082 | 0.0833 |
Echinococcus multilocularis | DNA dependent protein kinase catalytic subunit | 0.1313 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0271 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0271 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0271 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0271 | 1 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0091 | 0.0271 | 0.5 |
Trypanosoma brucei | phosphatidylinositol 3-related kinase, putative | 0.0091 | 0.0271 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0271 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0271 | 1 |
Echinococcus granulosus | neuropeptide receptor | 0.0193 | 0.1082 | 0.0833 |
Schistosoma mansoni | neuropeptide receptor | 0.0193 | 0.1082 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0271 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0271 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0271 | 1 |
Entamoeba histolytica | phosphatidylinositol3-kinaseTor2, putative | 0.0091 | 0.0271 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0271 | 1 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.0091 | 0.0271 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0271 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0271 | 1 |
Entamoeba histolytica | FKBP-rapamycin associated protein (FRAP), putative | 0.0091 | 0.0271 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0271 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0271 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0271 | 1 |
Trypanosoma brucei | phosphatidylinositol 3-kinase, putative | 0.0091 | 0.0271 | 1 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0091 | 0.0271 | 0.5 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.0091 | 0.0271 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0271 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0271 | 1 |
Giardia lamblia | GTOR | 0.0091 | 0.0271 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0271 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0459 | 0.32 | 1 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0091 | 0.0271 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0271 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0271 | 1 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0091 | 0.0271 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0271 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0271 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0091 | 0.0271 | 1 |
Echinococcus multilocularis | neuropeptide receptor | 0.0193 | 0.1082 | 0.0833 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Kd (binding) | = 590 nM | Displacement of l25I-PYY from Neuropeptide Y receptor type 2 of human neuroblastoma SK-N-BE cells | ChEMBL. | 1433176 |
Kd (binding) | = 590 nM | Displacement of l25I-PYY from Neuropeptide Y receptor type 2 of human neuroblastoma SK-N-BE cells | ChEMBL. | 1433176 |
Kd (binding) | > 1000 nM | Displacement of l25I-PYY from Neuropeptide Y receptor type 1 of human neuroblastoma SK-N-MC cells | ChEMBL. | 1433176 |
Kd (binding) | > 1000 nM | Displacement of l25I-PYY from Neuropeptide Y receptor type 1 of human neuroblastoma SK-N-MC cells | ChEMBL. | 1433176 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.